Bicalutamide
Advanced carcinoma of prostate in combination therapy with a luteinizing hormone releasing hormone (LHRH) analon.
50mg once daily.
Hypersensitivity to drug or any component of the product.
Hepatic impairment (if transaminases increase over 2 times the upper limit of normal, discontinue the treatment with this drug.
Patients when treated with Bicalutamide in combination with LHRH analog may have Hot flashes, diarrhoea, oedema, neoplasm, fever, neck pain, chills, sepsis.
| Brand Name | Manufactured by |
|---|---|
| ABROS HAIR SERUM | ABROS (DIVISION OF LUMAIRE LABS PVT. LTD.) |
